What We Know About COVID-19’s Effects on Child and Maternal Health
NIH Director's Blog, July 31, 2020
NIH Director's Blog, July 31, 2020
Association between Alzheimer's disease and COVID-19: A bidirectional Mendelian randomization
D Liu et al, MEDRXIV, July 30, 2020
D Liu et al, MEDRXIV, July 30, 2020
Initial evaluation of a mobile SARS-CoV-2 RT-LAMP testing strategy
C Newman et al, MEDRXIV, July 30, 2020
C Newman et al, MEDRXIV, July 30, 2020
How does SARS-CoV-2 cause COVID-19?
NJ Matheson, et al, Science, July 31, 2020
NJ Matheson, et al, Science, July 31, 2020
As with all coronaviruses, SARS-CoV-2 cell entry is dependent on its 180-kDa spike (S) protein, which mediates two essential events: binding to ACE2 by the amino-terminal region, and fusion of viral and cellular membranes through the carboxyl-terminal region.
Swabs Collected by Patients or Health Care Workers for SARS-CoV-2 Testing.
Tu Yuan-Po et al. The New England journal of medicine 2020 07 (5) 494-496
Tu Yuan-Po et al. The New England journal of medicine 2020 07 (5) 494-496
Our study shows the clinical usefulness of tongue, nasal, or mid-turbinate samples collected by patients as compared with nasopharyngeal samples collected by health care workers for the diagnosis of Covid-19.
Covid's Color Line - Infectious Disease, Inequity, and Racial Justice.
Evans Michele K et al. The New England journal of medicine 2020 Jul (5) 408-410
Evans Michele K et al. The New England journal of medicine 2020 Jul (5) 408-410
Drug treatments for covid-19: living systematic review and network meta-analysis
RAC Siemieniuk et al, BMJ, July 30, 2020
RAC Siemieniuk et al, BMJ, July 30, 2020
Glucocorticoids probably reduce mortality and mechanical ventilation in patients with covid-19 compared with standard care. The effectiveness of most interventions is uncertain because most of the randomised controlled trials so far have been small and have important study limitations.
No hay comentarios:
Publicar un comentario